Sigma Planning Corp’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.32M Buy
7,201
+1,955
+37% +$360K 0.04% 465
2025
Q4
$923K Buy
+5,246
New +$857K 0.03% 560
2023
Q1
Sell
-948
Closed -$263K 1301
2022
Q4
$263K Sell
948
-735
-44% -$208K 0.01% 1021
2022
Q3
$449K Sell
1,683
-32
-2% -$6.8K 0.02% 775
2022
Q2
$350K Sell
1,715
-78
-4% -$15.9K 0.01% 916
2022
Q1
$378K Buy
+1,793
New +$390K 0.01% 963
2021
Q3
Sell
-2,365
Closed -$819K 1391
2021
Q2
$819K Sell
2,365
-903
-28% -$274K 0.02% 629
2021
Q1
$914K Buy
3,268
+259
+9% +$69.8K 0.03% 536
2020
Q4
$737K Buy
3,009
+1,862
+162% +$480K 0.03% 543
2020
Q3
$325K Sell
1,147
-235
-17% -$65.5K 0.01% 766
2020
Q2
$370K Sell
1,382
-197
-12% -$59.2K 0.02% 702
2020
Q1
$500K Buy
1,579
+388
+33% +$118K 0.03% 483
2019
Q4
$353K Buy
+1,191
New +$330K 0.01% 721
2019
Q3
Sell
-969
Closed -$227K 1011
2019
Q2
$227K Buy
+969
New +$224K 0.01% 855
2018
Q4
Sell
-810
Closed -$286K 861
2018
Q3
$286K Buy
810
+4
+0.5% +$1.38K 0.02% 716
2018
Q2
$234K Buy
+806
New +$227K 0.02% 756
2018
Q1
Sell
-994
Closed -$317K 862
2017
Q4
$317K Buy
994
+234
+31% +$75.1K 0.02% 581
2017
Q3
$238K Buy
+760
New +$225K 0.02% 701

Other funds holding BIIB

Sigma Planning Corp's BIIB Position: Q1 2026 in Review

Sigma Planning Corp increased its Biogen (BIIB) stake by 37% in Q1 2026, buying an estimated $360K and bringing the position to 7,201 shares worth $1.32M. The position accounts for 0.04% of the portfolio, ranked #465.

Sigma Planning Corp first reported a position in BIIB in Q3 2017 and has held it in 18 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Sigma Planning Corp held 7,201 shares of Biogen worth $1.32M as of Q1 2026.
  • Sigma Planning Corp bought 1,955 Biogen shares in Q1 2026, an estimated $360K.
  • Biogen made up 0.04% of Sigma Planning Corp's portfolio in Q1 2026, its #465 holding.
  • Sigma Planning Corp first reported a position in Biogen in Q3 2017 and has held it in 18 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Sigma Planning Corp's 13F filing for Q1 2026, filed 4 May 2026.